Skip to main content
Clinical Trials/NCT00768924
NCT00768924CompletedNot Applicable

CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest

Zimmer Biomet1 site in 1 country35 target enrollmentStarted: March 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
35
Locations
1
Primary Endpoint
Data obtained by this study will provide valuable insight on the ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.

Study Overview

Brief Summary

The CopiOs Bone Void Filler (BVF) is a synthetic bone graft material consisting of calcium phosphate dehydrate within lyophilized type I bovine collagen that has been formed into pads of various sizes for surgical implantation. Pre-clinical animal studies suggest that the bone healing strength of CopiOs to be equivalent to autograft.

Detailed Description

Purpose of the study is to evaluate the in-vivo use of CopiOs bone void filler in a single site trial, providing pre and post-operative evaluations of subjects undergoing spinal fusion with autogenous bone graft, in whom the CopiOs has been used as a bone void filler in the post-harvest iliac crest.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient is 18 years and older
  • Patient must be an appropriate candidate for iliac crest bone harvesting during a spinal fusion.
  • Patient must be skeletally mature.
  • Patient has signed an IRB approved Informed Consent and HIPAA compliant waiver.

Exclusion Criteria

  • Patient is suffering from any co-morbidities that would excessively increase the risk of surgery, including but not limited to pulmonary or cardiac conditions.
  • Patient is pregnant.
  • Patient has a severe degenerative bone disease.
  • Patient has systemic conditions which would affect bone or wound healing.
  • Patient is unwilling or unable to follow postoperative instructions or cooperate in a follow-up program.
  • Patient is suffering from mental illness, alcohol abuse or drug abuse.
  • Patient has known allergies to bovine collagen.
  • Patient has a history of multiple allergies.
  • Patient has infection at the surgical site.
  • Significantly impaired vascularity proximal to surgical site.
  • Sites are in direct contact with articular space.
  • Sites where stresses on void will exceed the load strength of fixation hardware.
  • Patient has hypercalcemia.

Outcomes

Primary Outcomes

Data obtained by this study will provide valuable insight on the ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.

Time Frame: 6 Months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

CopiOs(TM) Bone Void Filler in the... | Clinical Trial